Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
American Neurological Association Annual Meeting
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Posturography in MS patients treated with high dose methylprednisolone.
Regulation of B cell function by the immunosuppressive agent leflunomide.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Ampyra (dalfampridine)
Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.

Pages